Clinical trials
Phase 2 Parasomnias trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Recruiting | 1 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Johns Hopkins University | 4 |
| Duke University | 2 |
| University of Utah | 2 |
| Baylor College of Medicine | 1 |
| Bod Australia | 1 |
| Chang Gung Memorial Hospital | 1 |
| Columbia Northwest Pharmaceuticals | 1 |
| Kaiser Permanente | 1 |
| Lallemand Health Solutions | 1 |
| Mariana Cherner, PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parasomnias | 26 |
| Anxiety Disorders | 5 |
| Sleep Initiation and Maintenance Disorders | 4 |
| Stress Disorders, Post-Traumatic | 4 |
| Post-Acute COVID-19 Syndrome | 3 |
| Sleep Apnea Syndromes | 3 |
| Sleep Wake Disorders | 3 |
| Alzheimer Disease | 2 |
| Disorders of Excessive Somnolence | 2 |
| Opioid-Related Disorders | 2 |
Trials
Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.